4th Quarter - Report

FEROX STRATEGIES for ELI LILLY AND COMPANY

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues related to the pharmaceutical industry. (H.R.1577 and S. 596) - Treat and Reduce Obesity Act of 2021.

LobbyistCovered position, as disclosed
CRISTINA ANTELO —
DEBRA DIXON —
MARK WILLIAMS —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1577 (117th), S. 596 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.